Published Date: 26 Apr 2023
In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.
Read Full NewsTechnique deemed safe and feasible for selected patients and better than other minimally invasive approaches
Cardiomyopathy risks interrupting cancer treatment, worsening prognosis
— News, features, and commentary about cancer-related issues
1.
FDA Approves Hemophilia B Second Gene Therapy.
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
4.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
5.
Durvalumab Wins FDA Approval in Limited-Stage SCLC
1.
Oncology Communication Simulation: Enhancing Clinical Competence Through Evidence-Based Training
2.
Transformative Frameworks in Oncology for Better Care
3.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
4.
Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care
5.
Hematologic Fatigue and Work Function: Clinical Implications, Pathophysiology, and Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation